Has Cameron Dezfulian received payments from drug or device companies?

Yes. Drug and device makers reported $1,250 in general payments to Cameron Dezfulian across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cameron Dezfulian did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cameron Dezfulian come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cameron Dezfulian

Pediatric Critical Care Medicine · Miami, FLNPI 1578563565

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $900 of the $1,250 with a category attached, or 72.0%. 8 manufacturers reported payments, led by Edwards Lifesciences at 41.0% of the total. Reporting peaked in 2024 at $1,142 and has fallen 97.0% since, to $34 in 2025. Among pediatric critical care medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,250in general payments, 2019–2025

Across 14 payments — averaging $89.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$513
W. L. Gore & Associates, Inc.$207
Medtronic$167
AstraZeneca$118
Getinge USA Sales, LLC$96
Angiodynamics, Inc.$58
plus $91 from 2 others

$355,158in research payments, 2019–2025

Across 3 payments — averaging $118,386 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Mallinckrodt Hospital Products Inc.$211K
Mallinckrodt Enterprises LLC$144K

What the payments were for

Consulting fees$35028%
Food & beverage$90072%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	2	$513
W. L. Gore & Associates, Inc.	1	$207
Medtronic	2	$167
AstraZeneca	1	$118
Getinge USA Sales, LLC	2	$96
Angiodynamics, Inc.	2	$58
Abiomed	2	$50
Abbott	2	$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,250 in reported general payments places this provider in the 95th percentile of 126 pediatric critical care medicine providers in Florida.

See all pediatric critical care medicine providers in Florida →

Other pediatric critical care medicine in Miami

Jennifer Munoz ParejaMiami$2K
Juan SolanoMiami$2K
Thy TranMiami$464
Michael LeoncioMiami$382
Fernando PerezMiami$252
Arcenio ChaconMiami$229
Jeronimo RamirezMiami$198
Anna PelligraMiami$192
Darline Santana-AcostaMiami$159
Alejandro Martinez HerradaMiami$151

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →